Table 1 (abstract P397). Selected outcomes at last clinic visit for patients recruited at one ReACCh-Out center
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Group | Age in years | Years since diagnosis | Active disease | Remission on meds | Remission off meds | Still on treatment | X-ray damage | Uveitis complications. |
|---|---|---|---|---|---|---|---|---|
Oligoarthritis (n=93) | 14.1 (11.8, 17.1) | 7.8 (2.8, 10.1) | 19 (20%) | 26 (28%) | 46 (49%) | 45 (48%) | 8 (9%) | 2 (2%) |
ERA (n=51) | 17.9 (16.9, 18.1) | 4.6 (3.0, 6.2) | 17 (33%) | 7 (14%) | 27 (53%) | 24 (47%) | 9 (18%) | 0 |
Poly RF-Neg (n=39) | 17.7 (12.8, 18.1) | 5.4 (3.8, 8.1) | 16 (41%) | 10 (26%) | 12 (31%) | 24 (62%) | 6 (15%) | 0 |
Systemic (n=22) | 17.1 (15.5, 17.6) | 5.8 (3.7, 8.1) | 2 (9%) | 5 (23%) | 15 (68%) | 7 (32%) | 4 (18%) | 0 |
Psoriatic (n=9) | 18.1 (17.1, 18.2) | 5.4 (4.3, 5.7) | 2 (22%) | 2 (22%) | 5 (56%) | 4 (44%) | 5 (56%) | 0 |
Poly-RF-Pos (n=9) | 17.9 (16.2, 18.6) | 6.0 (5.6, 8.1) | 4 (44%) | 4 (44%) | 1 (11%) | 7 (78%) | 4 (44%) | 0 |
Undifferentiated (n=13) | 17.1 (9.7, 17.7) | 6.3 (4.7, 7.7) | 4 (31%) | 2 (15%) | 7 (54%) | 6 (46%) | 4 (31%) | 0 |
All (n=236) | 17.0 (13.0, 18.0) | 5.6 (3.4, 8.2) | 64 (27%) | 56 (24%) | 113 (48%) | 117 (50%) | 40 (17%) | 2 (0.9%) |